Navigation Links
New technique sees into tissue at greater depth, resolution
Date:9/17/2008

re then applied to the surface of a three-dimensional tissue model composed of human cells both cancerous and non-cancerous. Skala hoped that these antibodies would home in on cells that were overproducing EGFR on their surfaces, an indicator of cancerous activity. Then the photothermal OCT would be able to detect them by showing where the gold spheres were concentrated.

"When we directed the photothermal OCT at the tissue, we found that the cells that were overexpressing EGFR gave off a signal 300 percent higher than cells with low expressions of EGFR," Skala said.

Adding heat to this form of microscopy technique created a phenomenon much like that seen on very hot days, when portions of the pavement far in the distance seem to float or hover above the road.

"The heat causes a distortion in the way light is reflected off the gold nanospheres in a characteristic way," Skala explained. "As we changed the temperature, the light pathways would change in measurable ways."

In this manner, Skala explained, they were not only able to "see" cells within the tissue, but they were able to capture the molecular function of an antibody attaching to a receptor.

"The use of metal nanoparticles as contrast agents with photothermal OCT technology could lead to a host of potential clinical applications," Izatt said. "Organically-based contrast agents can cause damage or death to the targeted cells, while metal nanospheres are relatively safer."

"Also, given the wide range of nanoparticle shapes and sizes, coupled with the ability to 'tune" the optical wavelength of the OCT, we can customize our approach to many different target types," Izatt said.

Skala plans to expand the use of this approach in animal models to better understand the role of different cancer therapies. Tumors with elevated levels of EGFR are known to have a poor prognosis, and she plans to use photothermal OCT to measure how these tumor types react to
'/>"/>

Contact: Richard Merritt
richard.merritt@duke.edu
919-660-8414
Duke University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Cryopreservation techniques bring hopes for women cancer victims and endangered species
2. Improved technique determines structure in membrane proteins
3. Resuscitation technique after brain injury may do more harm than good
4. New electrostatic-based DNA microarray technique could revolutionize medical diagnostics
5. Technique used in human ankle injuries modified to treat dogs knees
6. Dinosaur diggers bring mobile lab, new techniques to Eastern Montana
7. Spradling receives Gruber Foundation Genetics Prize for new genetic techniques
8. New technique allows targeted inactivation of genes in research model
9. Spin control: New technique sorts nanotubes by length
10. Development of new techniques to understand marble quality and durability
11. New technique determines the number of fat cells remains constant in all body types
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... San Diego, California, has been awarded an accreditation ... on results of a recent onsite inspection. ... this national recognition and congratulated for the "excellence ... GenWay Clinical Laboratory is one of nearly 7,000 ... Program, begun in the early 1960s, is recognized ...
(Date:12/15/2009)... found the fossil remains of a whale, 4.5 million years ... first time, the results of the decay and fossilisation process ... a baleen whale from the Mysticeti group. , This is ... a whale from the Lower Pliocene (five million years ago) ... first time that the results of the processes of fossilisation ...
(Date:12/15/2009)... model organism, but there are currently few resources ... blood-forming tissues in this species. A newly ... from Cold Spring Harbor Laboratory Press fills this ... protocols for the preparation, enumeration, and microscopic examination ... tissues in the mouse. The laboratory manual ...
Breaking Biology News(10 mins):Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3New source of classical techniques for blood-based studies in the laboratory mouse 2Mylans Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla 28R 29 HIV Treatment 54751 1Mylans Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla 28R 29 HIV Treatment 54751 2Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 1Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 2Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 3Anthem Blue Cross and Blue Shield in New Hampshire Announces Decision to Cover H1N1 Vaccine Administration 54744 1Anthem Blue Cross and Blue Shield in New Hampshire Announces Decision to Cover H1N1 Vaccine Administration 54744 2
... -- 12 AUGUST 2008 -- More than 10,000 ... at the George R. Brown Convention Center in ... latest research and trends in energy, water resources, ... related disciplines. , This first-ever Joint Annual Meeting ...
... The first study to compare the performance of different ... Lady Bird Johnson Wildflower Center at The University of ... these roofs are created equal. , Interest in vegetated ... more important to property owners. Yet the study of ...
... wheat disease strain which could lead to a global wheat ... States, with funding from the Bill & Melinda Gates Foundation ... as part of the Durable Rust Resistance in Wheat project ... stem rust. , World leaders in rust research Dr ...
Other Biology News:Scientists team up in Houston to tackle global challenges 2Scientists team up in Houston to tackle global challenges 3Scientists team up in Houston to tackle global challenges 4Green roofs differ in building cooling, water handling capabilities 2Green roofs differ in building cooling, water handling capabilities 3CSIRO enlisted to avert global wheat supply crisis 2
(Date:12/15/2009)... Epeius Biotechnologies Corporation, an emerging leader in the ... of the cutting-edge science behind its lead oncology ... world rediscovered the Cyclin G1 gene ... and disease progression, and thus a prime target ... National Cancer Institute investigating the role of microRNAs ...
(Date:12/15/2009)... Repligen Corporation (Nasdaq: RGEN ) today announced ... funding to support the ongoing development of new ... Association (MDA). This grant will support the ... manufacture of a drug candidate for human clinical ... provides important funding for Repligen,s research but it ...
(Date:12/15/2009)... Reportlinker.com announces that a new market research ... The Future of Orphan Diseases ... Analysis and Reimbursement ,, ... Summary ,, The author has released ... Diseases Therapeutics - Market Forecasts to 2015, ...
(Date:12/15/2009)... WILMINGTON, Del. and CHARLOTTESVILLE, Va., Dec. 15 ... ) and the University of Virginia (UVa) ... entered into a strategic research collaboration to ... coronary artery disease (CAD) with a secondary ... (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) ,, The ...
Breaking Biology Technology:Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3
... Sept. 17 /Xinhua-PRNewswire/ -- Shandong Zhouyuan Seed,and Nursery ... "Parent,Corporation") which is incorporated in the State of ... Shandong Zhouyuan Seed and,Nursery Co., Ltd. ("Zhouyuan" or ... agreement with Linyi Kun Yuan Seeds Co., Ltd. ...
... HAMILTON, Bermuda, Sept. 17 Warner Chilcott,Limited (Nasdaq: ... has,received a non-final Action Closing Prosecution from the U.S. ... USPTO ordered a,reexamination of LEO,s US Patent No. 6,753,013 ... Galderma R&D. The 013 Patent covers TACLONEX,and certain of ...
... LMNX ) today announced that management will present at ... September,17-20, 2007, at the St. Regis Hotel in San ... president and chief,executive officer, will begin at 11:00 a.m. ... 2007. The presentation will be webcast live,and may be ...
Other Biology Technology:Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company 2Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company 3Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent 2Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent 3Luminex Corporation to Present at ThinkEquity Partners Investor Conference 2